Opthea (OPT) News Today $3.41 +0.23 (+7.23%) As of 03/24/2025 Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Oppenheimer Downgrades Opthea (NASDAQ:OPT) to Market PerformOppenheimer lowered Opthea from an "outperform" rating to a "market perform" rating in a report on Monday.March 25 at 1:18 PM | marketbeat.comHold Rating Issued for Opthea Limited Amid Uncertainty Following Phase 3 Trial FailureMarch 25 at 9:20 AM | tipranks.comOpthea Limited: Hold Rating Amid Phase 3 Trial Failure and Financial UncertaintyMarch 25 at 3:25 AM | tipranks.comOpthea COAST trial misses primary endpoint, enters talks with DFA InvestorsMarch 24 at 11:52 PM | markets.businessinsider.comAmid fears of collapse, what's happening with Opthea ASX shares today?March 24 at 11:52 PM | msn.comMonday’s HotCopper Trends: Opthea strife, Memphasys best-in-class results | March 21, 2025March 24 at 9:55 AM | msn.comOpthea's Phase 3 trial results fail to help patients, future of company at riskMarch 24 at 9:55 AM | msn.comOpthea Phase 3 Trial Fails To Meet Primary Endpoint, Faces Financial UncertaintyMarch 24 at 9:55 AM | benzinga.comOpthea Announces COAST Phase 3 Trial Topline ResultsMarch 24 at 12:01 AM | globenewswire.comOpthea Limited Suspends Trading Pending Clinical Trial ResultsMarch 18, 2025 | tipranks.comHealth Check: Awaiting key announcements, these biotechs could use some Irish luckMarch 16, 2025 | msn.comOpthea Limited Initiates Trading Halt Ahead of Key Clinical Trial ResultsMarch 16, 2025 | tipranks.comOpthea (NASDAQ:OPT) Shares Gap Up - Time to Buy?Opthea (NASDAQ:OPT) Shares Gap Up - Still a Buy?March 15, 2025 | marketbeat.comOpthea (NASDAQ:OPT) Trading 3.6% Higher - Here's What HappenedOpthea (NASDAQ:OPT) Stock Price Up 3.6% - Here's What HappenedMarch 14, 2025 | marketbeat.comJPMorgan Acquires Substantial Stake in Opthea LimitedMarch 14, 2025 | tipranks.comOpthea Limited Announces Quotation of New Securities on ASXMarch 14, 2025 | tipranks.comOpthea Limited Announces New Quotation of Securities on ASXMarch 14, 2025 | tipranks.comOpthea Limited Announces New Securities Quotation on ASXMarch 10, 2025 | tipranks.comOpthea Limited Announces New Securities Quotation on ASXMarch 10, 2025 | tipranks.comOpthea Limited (OPT): Among the Best Australian Stocks to Buy According to BillionairesMarch 10, 2025 | finance.yahoo.comOpthea (NASDAQ:OPT) Sees Unusually-High Trading Volume - Should You Buy?Opthea (NASDAQ:OPT) Sees Large Volume Increase - Time to Buy?March 8, 2025 | marketbeat.comOpthea (NASDAQ:OPT) Shares Gap Up - Still a Buy?Opthea (NASDAQ:OPT) Shares Gap Up - Here's What HappenedMarch 6, 2025 | marketbeat.comOpthea (NASDAQ:OPT) Trading Down 10.5% - Should You Sell?Opthea (NASDAQ:OPT) Trading Down 10.5% - Here's What HappenedMarch 5, 2025 | marketbeat.comOpthea (NASDAQ:OPT) Trading Up 4.2% - Here's WhyOpthea (NASDAQ:OPT) Stock Price Up 4.2% - Still a Buy?March 4, 2025 | marketbeat.comOpthea Announces Phase 2b Wet AMD PublicationMarch 3, 2025 | globenewswire.comOpthea Limited Reports Increased Loss Amid Clinical ProgressMarch 2, 2025 | tipranks.comOpthea Limited Reports Increased Losses Amid Clinical AdvancementsMarch 2, 2025 | tipranks.comOpthea announces anticipated milestonesMarch 1, 2025 | markets.businessinsider.comHC Wainwright Reiterates "Buy" Rating for Opthea (NASDAQ:OPT)HC Wainwright reissued a "buy" rating and set a $12.00 target price on shares of Opthea in a research note on Friday.March 1, 2025 | marketbeat.comOpthea reports 1H adjusted EPS ($5.73) vs. ($14.25) last yearFebruary 28, 2025 | markets.businessinsider.comOpthea Reports Half Year Results and Business UpdatesFebruary 28, 2025 | finance.yahoo.comOpthea Completes Drug Product PPQ CampaignFebruary 26, 2025 | markets.businessinsider.comOpthea Advances Sozinibercept with Successful PPQ Campaign CompletionFebruary 25, 2025 | tipranks.comOpthea Limited Announces New Securities Quotation on ASXFebruary 21, 2025 | tipranks.comOpthea (NASDAQ:OPT) Shares Gap Down - Time to Sell?Opthea (NASDAQ:OPT) Shares Gap Down - What's Next?February 19, 2025 | marketbeat.comOpthea (OPT) Projected to Post Earnings on WednesdayOpthea (NASDAQ:OPT) will be releasing earnings before the market opens on Wednesday, February 26.February 19, 2025 | marketbeat.comOpthea Limited Announces New Securities Quotation on ASXFebruary 17, 2025 | tipranks.comIs Opthea Limited (OPT) the Best Long Term ASX Stock to Buy Now?February 11, 2025 | insidermonkey.comOpthea Limited Announces Quotation of New SecuritiesFebruary 11, 2025 | tipranks.comOpthea Limited Announces Cessation of 3 Million SecuritiesFebruary 11, 2025 | tipranks.comOpthea (NASDAQ:OPT) Shares Down 4.1% - What's Next?Opthea (NASDAQ:OPT) Stock Price Down 4.1% - Here's WhyFebruary 10, 2025 | marketbeat.comOpthea to Present at Oppenheimer Healthcare ConferenceFebruary 7, 2025 | globenewswire.comOpthea (NASDAQ:OPT) Hits New 52-Week High - Here's What HappenedOpthea (NASDAQ:OPT) Hits New 12-Month High - Should You Buy?February 7, 2025 | marketbeat.comOpthea (NASDAQ:OPT) Sees Strong Trading Volume - Here's WhyOpthea (NASDAQ:OPT) Sees Large Volume Increase - Here's WhyFebruary 6, 2025 | marketbeat.comOpthea (NASDAQ:OPT) Stock Price Down 9% - Time to Sell?Opthea (NASDAQ:OPT) Shares Down 9% - Should You Sell?February 3, 2025 | marketbeat.comOpthea Limited (NASDAQ:OPT) Short Interest UpdateOpthea Limited (NASDAQ:OPT - Get Free Report) was the target of a significant increase in short interest in January. As of January 15th, there was short interest totalling 141,500 shares, an increase of 113.1% from the December 31st total of 66,400 shares. Based on an average daily trading volume, of 27,200 shares, the days-to-cover ratio is currently 5.2 days.January 31, 2025 | marketbeat.comIs Opthea Limited (OPT) One of the Best ASX Stocks to Buy According to Hedge Funds?January 31, 2025 | insidermonkey.comOpthea (NASDAQ:OPT) Sets New 1-Year High - Time to Buy?Opthea (NASDAQ:OPT) Reaches New 1-Year High - Here's WhyJanuary 30, 2025 | marketbeat.comOpthea: Small Australian Company Aiming To Upend The Wet AMD MarketJanuary 30, 2025 | seekingalpha.comOpthea Limited: Promising Outlook with Sozinibercept in wAMD and Pivotal Trials on TrackJanuary 30, 2025 | markets.businessinsider.com Remove Ads Get Opthea News Delivered to You Automatically Sign up to receive the latest news and ratings for OPT and its competitors with MarketBeat's FREE daily newsletter. Email Address OPT Media Mentions By Week OPT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OPT News Sentiment▼-0.550.63▲Average Medical News Sentiment OPT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OPT Articles This Week▼152▲OPT Articles Average Week Remove Ads Get Opthea News Delivered to You Automatically Sign up to receive the latest news and ratings for OPT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ARQT News TARS News HRMY News TVTX News JANX News IRON News AGIO News APGE News MESO News VERA News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:OPT) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Opthea Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Opthea With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy OPT Stock Free OPT Stock Alerts